<DOC>
	<DOCNO>NCT02197156</DOCNO>
	<brief_summary>The purpose study establish dose-response relationship among several capsule strength Hydrocodone Bitartrate Extended Release ( HC-ER ) compare efficacy placebo follow bunionectomy surgery</brief_summary>
	<brief_title>A Multicenter Active Comparator Study HC-ER Adults Following Bunionectomy Surgery</brief_title>
	<detailed_description>Sum Pain Intensity Differences ( SPID ) Primary pain measurement : VASPI ( Visual Analog Scale Pain Intensity ) time 0 12 hr ; Safety evaluation assess : laboratory evaluation , physical examination , vital signs/pulse oximetry electrocardiography</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Subject able read voluntarily sign Institutional Review Board ( IRB ) approve , write informed consent document give opportunity ask question regard study prior performance study specific procedure . Subject require primary unilateral first metatarsal bunionectomy surgery without hammertoe repair collateral procedure allow Subject male female least 18 year age . Subject weigh &gt; = 100 lb ( pound ) . Subject willing able comply protocol able score pain intensity . Subject good health determine investigator basis medical history , physical examination , Electrocardiogram ( ECG ) screen laboratory result . Subject develop condition complication result bunionectomy procedure would preclude participation study . Subject willing able remain recovery day care center entire 24hour Treatment period . Subject pregnant lactating . Subject investigational drug within 30 day prior initiation study drug . Subject donate blood blood component within one month prior study ( Checkin ) . Subject know allergy hypersensitivity opioids , acetaminophen , and/or ketorolac . Subject known history substance alcohol abuse within 2 year prior Screening . Subject test positive drug screen ( cocaine , marijuana , opioids , benzodiazepine , barbiturate ) could justify prescription use . Subject condition would contraindicate use opioid analgesia ( e.g. , pulmonary disease paralytic ileus ) . Subject receive selective serotonin reuptake inhibitor ( SSRI ) , monoamine oxidase inhibitor ( MAOI ) carbamazepine , quinidine , and/or tricyclic antidepressant ( TCA ) compound within 1month prior Checkin . Subject receive opioids , tranquilizer , sedative , hypnotic within 48 hour prior Checkin . Subject receive corticosteroid , nonsteroidal antiinflammatory drug ( NSAIDs ) , analgesic within 24 hour prior Checkin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>